Tune in to “Advancements with Ted Danson” to discover how Fibrocor Therapeutics is leading the charge in reshaping the future of fibrosis treatment. Join William Newsome, President and CEO, Dr. Richard Gilbert, Chief Scientific Officer, Piet Wigerinck, Chief Scientific Advisor, Toby Maher, Professor of Clinical Medicine USC and Fibrocor’s Scientific Advisory Board, and Patient/Parent advocate Lisa Bonebrake from the Alport Syndrome Foundation as they delve into the promising advancements in fibrosis treatment.